Author

Niels Fertig

Nanion (Germany)ORCID 0000-0002-9731-2283Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1

Frequent Co-Authors

Aaron L. RandolphiD· 1 shared Alison Obergrussberger· 1 shared Bita Asghariastanehei· 1 shared Cyril Castelbou· 1 shared Dale GeorgeiD· 1 shared Élie NaderiD· 1 shared Franciele de LimaiD· 1 shared Gorane Rodríguez-Urquirizar· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Aaron L. RandolphORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transcriptomic analysis and high throughput functional characterization of human induced pluripotent stem cell derived sensory neurons

Vincent Truong, Jackson Brougher, Tim Strassmaier, Irene Lu, Dale George, Theodore John Price, Alison Obergrussberger, Aaron L. Randolph, Rodolfo Jorge Haedo, Niels Fertig, Patrick Walsh

This study develops a novel method to generate human induced pluripotent stem cell-derived sensory neurons that closely resemble primary human tissue transcriptionally and functionally.

Neurobiology of Pain · May 1, 2026Peer-reviewedCell Biology

Otenabant is a Selective Antagonist of Human PIEZO1

Vincent Jaquet, Reeta Penttinen, Gorane Rodríguez-Urquirizar, Cyril Castelbou, Yves Cambet, Nicolas Rosa, Mathilde Bourdin, Bita Asghariastanehei, Franciele de Lima, Marie Martin, Élie Nader, Selma Angèlica Serra, José M. Fernández‐Fernández, Nicoletta Murciano, Philippe Connes, , Nicolas Demaurex

The paper identifies Otenabant, a CB1 antagonist, as a potent and selective PIEZO1 inhibitor through high-throughput screening and validates its effects across multiple assays.

bioRxiv · Apr 30, 2026 · PreprintPharmacology & Toxicology